The development of custom antibodies is a critical component in advancing research and therapeutic innovation. Biointron, a Contract Research Organization (CRO) specializing in antibody expression services, provides comprehensive support to biotech companies seeking reliable, high-quality, and large-scale antibody production services.
Expertise in Antibody Discovery and Expression
Biointron’s core strength lies in its expertise in the discovery, engineering, and antibody production services of custom antibodies. The company employs advanced platforms for hybridoma development, phage display technology, and recombinant antibody expression to cater to a broad range of applications, including diagnostics, therapeutics, and basic research.
One of Biointron’s key offerings is Abinvivo, a Biointron brand that provides in vivo antibodies and reagents for research use. Biointron’s catalog products for in vivo research can be found at Abinvivo, where we have a wide range of Benchmark Positive Antibodies, Isotype Negative Antibodies, Anti-Mouse Antibodies, Bispecific Antibodies, and Antibody-Drug Conjugates.
Related: Abinvivo’s In Vivo Antibody Products: Differences in V3, V6, and V9
Abinvivo also integrates analytical validation as part of our services. This ensures that each batch of antibodies meets the purity, stability, and functional requirements critical for success in downstream applications.
Supporting Therapeutic Antibody Development
The therapeutic antibody market continues to grow, driven by innovations in immuno-oncology, autoimmune disease therapies, and infectious disease research. Biointron supports these efforts by offering services like humanization of monoclonal antibodies, a key step in transitioning murine-derived antibodies for human clinical applications.
A Trusted Partner for Antibody R&D
Biointron is committed to maintaining transparent communication and collaboration throughout the project lifecycle. Our team of scientists works closely with clients to ensure the antibody development process aligns with project goals, budgets, and timelines.
For biotech firms navigating complex research demands, partnering with Biointron offers a streamlined approach to custom antibody development. Our integrated solutions, technical expertise, and focus on quality provide the support necessary to bring innovative antibody-based products to market.
Biointron announces limited-time RushData launch pricing for high-throughput ant……
August 2026 brought another mix of acquisitions, licensing agreements, strategic……
Antibody discovery often begins with a highly diverse population of B cells, onl……
As larger candidate panels move from computational design into the laboratory, a……
You can also contact us on the Scientist and Science Exchange marketplaces.